ENDRA Life Sciences Inc.
NDRA
$4.09
-$0.0519-1.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.77M | -9.77M | -11.51M | -8.82M | -9.57M |
| Total Depreciation and Amortization | 178.80K | 196.10K | 206.20K | 221.00K | 237.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.95M | 2.97M | 3.77M | 1.80M | 1.18M |
| Change in Net Operating Assets | 56.10K | 50.50K | 134.10K | -1.27M | -857.00K |
| Cash from Operations | -5.58M | -6.55M | -7.40M | -8.06M | -9.00M |
| Capital Expenditure | -17.30K | -6.30K | -16.00K | -22.90K | -22.90K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 3.20K | 12.40K | 12.40K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -17.30K | -6.30K | -12.80K | -10.50K | -10.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -28.50K | -28.50K | -28.50K |
| Issuance of Common Stock | 1.00M | 7.48M | 7.84M | 8.49M | 9.61M |
| Repurchase of Common Stock | -6.69M | -6.69M | -6.69M | -6.69M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.69M | 6.69M | 6.69M | 7.70M | 1.01M |
| Cash from Financing | 1.00M | 7.49M | 7.81M | 9.48M | 10.59M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | -4.59M | 930.20K | 395.60K | 1.41M | 1.58M |